Jupiter Endovascular today announced the first two patients treated in a study of its Vertex pulmonary embolectomy system. Investigators treated two patients in the SPIRARE I study of the Vertex system using the company's Endoportal Control … [Read More...] about Jupiter Endovascular announces first cases with Vertex pulmonary embolectomy system
Main Content
Featured
Today on Medical Tubing & Extrusion
- Jupiter Endovascular announces first cases with Vertex pulmonary embolectomy system
- Edwards launches Sapien 3 valve with Alterra prestent in Europe
- Merit Medical to buy Cook Medical’s lead management portfolio
- FDA approves expanded label for Boston Scientific Ingevity+ pacing leads
- InspireMD submits carotid stent for FDA premarket approval
Medical Tubing & Extrusion
Jupiter Endovascular announces first cases with Vertex pulmonary embolectomy system
By Sean Whooley
Jupiter Endovascular today announced the first two patients treated in a study of its Vertex pulmonary embolectomy system. Investigators treated two patients in the SPIRARE I study of the Vertex system using the company's Endoportal Control … [Read More...] about Jupiter Endovascular announces first cases with Vertex pulmonary embolectomy system
Edwards launches Sapien 3 valve with Alterra prestent in Europe
By Sean Whooley
Edwards Lifesciences (NYSE:EW) announced that it launched its Sapien 3 transcatheter pulmonary valve implant (TPVI) system with Alterra adaptive prestent in Europe. The launch expands the continent’s minimally invasive treatment options to a … [Read More...] about Edwards launches Sapien 3 valve with Alterra prestent in Europe
Merit Medical to buy Cook Medical’s lead management portfolio
By Sean Whooley
Merit Medical Systems (Nasdaq:MMSI) announced today that it agreed to acquire Cook Medical's lead management portfolio for $210 million. Cook Medical's lead management business provides medical devices and accessories used in lead management … [Read More...] about Merit Medical to buy Cook Medical’s lead management portfolio
FDA approves expanded label for Boston Scientific Ingevity+ pacing leads
By Sean Whooley
Boston Scientific [WtwhTicker symbol="BSX"](NYSE: BSX)[/WtwhTicker] announced today that it received FDA approval to expand the indication for its current-generation Ingevity+ pacing leads. The expanded indication includes conduction system pacing … [Read More...] about FDA approves expanded label for Boston Scientific Ingevity+ pacing leads
InspireMD submits carotid stent for FDA premarket approval
By Sean Whooley
InspireMD (Nasdaq:NSPR) announced today that it submitted a premarket approval (PMA) application to the FDA for its CGuard system. The company designed the CGuard Prime carotid stent system, made from nitinol, for the treatment of carotid artery … [Read More...] about InspireMD submits carotid stent for FDA premarket approval
Penumbra wins CE mark for computer-assisted thrombectomy tech
By Sean Whooley
Penumbra (NYSE:PEN) announced today that it received CE mark approval for its computer-assisted vacuum thrombectomy (CAVT) technologies. The Lightning Flash 2.0 and Lightning Bolt 7 offerings from the Alameda, California-based company both picked … [Read More...] about Penumbra wins CE mark for computer-assisted thrombectomy tech
Biotronik earns expanded FDA nod for pacing lead, delivery catheter system
By Sean Whooley
Biotronik announced today that it received FDA approval for its Selectra 3D catheter and Solia S lead for use in left bundle branch area pacing (LBBAP). The FDA's approval of the new labeling for the pacing combination makes the products the first … [Read More...] about Biotronik earns expanded FDA nod for pacing lead, delivery catheter system